Sees Q1 reported revenue growth in the high single digits, with organic revenue at or above the 10% level y/y, consensus $981.09M. Expects stronger revenue growth rates in 1H23 due to the comparison to FY22 when the growth rate accelerated throughout the year and the gating of NHP supply impact; Only expect small impact related to NHP supply in 1Q23.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CRL: